Aztreonam-avibactam activity against Enterobacterales from Asia Pacific and Latin American medical centres: Summary of 5 years of surveillance prior to clinical use (2020–2024)
Publication date: December 2026 Source: International Journal of Antimicrobial Agents, Volume 67, Issue 12 Author(s): Helio S. Sader, Rodrigo E. Mendes, John H. Kimbrough, Krisztina M. Papp-Wallace, Mariana Castanheira
Aztreonam-avibactam activity against Enterobacterales from Asia Pacific and Latin American medical centres: Summary of 5 years of surveillance prior to clinical use (2020–2024). // International Journal of Antimicrobial Agents. – URL: https://www.sciencedirect.com/science/article/pii/S0924857926002906?dgcid=rss_sd_all
Aztreonam-avibactam activity against Enterobacterales from Asia Pacific and Latin American medical centres: Summary of 5 years of surveillance prior to clinical use (2020–2024). International Journal of Antimicrobial Agents. https://www.sciencedirect.com/science/article/pii/S0924857926002906?dgcid=rss_sd_all
“Aztreonam-avibactam activity against Enterobacterales from Asia Pacific and Latin American medical centres: Summary of 5 years of surveillance prior to clinical use (2020–2024).” International Journal of Antimicrobial Agents.
@article{article49507,
title = {Aztreonam-avibactam activity against Enterobacterales from Asia Pacific and Latin American medical centres: Summary of 5 years of surveillance prior to clinical use (2020–2024)},
journal = {International Journal of Antimicrobial Agents},
url = {https://www.sciencedirect.com/science/article/pii/S0924857926002906?dgcid=rss_sd_all}
}